- Home
- WPP vs LNTH Comparison
WPP vs LNTH Comparison
Compare WPP & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- LNTH
- Stock Information
- Founded
- WPP 1985
- LNTH 1956
- Country
- WPP United Kingdom
- LNTH United States
- Employees
- WPP N/A
- LNTH N/A
- Industry
- WPP Advertising
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- WPP Consumer Discretionary
- LNTH Health Care
- Exchange
- WPP Nasdaq
- LNTH Nasdaq
- Market Cap
- WPP 8.4B
- LNTH 7.5B
- IPO Year
- WPP N/A
- LNTH 2015
- Fundamental
- Price
- WPP $39.79
- LNTH $81.24
- Analyst Decision
- WPP Hold
- LNTH Strong Buy
- Analyst Count
- WPP 1
- LNTH 5
- Target Price
- WPP N/A
- LNTH $133.80
- AVG Volume (30 Days)
- WPP 294.8K
- LNTH 1.4M
- Earning Date
- WPP 02-27-2025
- LNTH 05-07-2025
- Dividend Yield
- WPP 3.00%
- LNTH N/A
- EPS Growth
- WPP 389.11
- LNTH N/A
- EPS
- WPP 0.62
- LNTH 3.53
- Revenue
- WPP $18,454,623,978.00
- LNTH $1,536,699,000.00
- Revenue This Year
- WPP N/A
- LNTH $4.96
- Revenue Next Year
- WPP $1.46
- LNTH $10.25
- P/E Ratio
- WPP $12.51
- LNTH $23.00
- Revenue Growth
- WPP N/A
- LNTH 12.53
- 52 Week Low
- WPP $31.52
- LNTH $74.34
- 52 Week High
- WPP $57.37
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- WPP 58.31
- LNTH 32.82
- Support Level
- WPP $38.46
- LNTH $77.01
- Resistance Level
- WPP $40.79
- LNTH $83.60
- Average True Range (ATR)
- WPP 0.47
- LNTH 3.77
- MACD
- WPP 0.26
- LNTH -2.21
- Stochastic Oscillator
- WPP 66.22
- LNTH 13.26
About WPP WPP plc
Headquartered in the United Kingdom, WPP is one of the world's largest ad holding companies based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.